Daicel Arbor Biosciences Introduces the Next Generation of myBaits Target Enrichment Panels
Ann Arbor, MI (August 31, 2020) – Daicel Arbor Biosciences a division of Chiral Technologies, Inc., and leader in developing molecular biology research tools, announces an advance in the latest myBaits kit reagent chemistry and associated protocol referred to as myBaits Version 5. Daicel Arbor, a division of Chiral Technologies, Inc., is a leader in developing molecular biology research tools.
The myBaits v5 kit offers enhanced benefits including:
- An updated chemistry with increased specificity and performance
- Three application-specific protocols in a convenient manual
o Standard (for most targeted seq applications)
o High-Sensitivity (for rare, degraded, and/or divergent targets)
o Long-Insert (for long-read NGS platforms)
- Expanded experimental tips and recommendations
“We are proud to continue our tradition of supporting a broad range of research applications with tailored solutions for maximizing your experimental performance,” said Alison Devault, Director of Genomics at Arbor Biosciences. “Our advanced new chemistry offers maximum enrichment performance with an expanded, user-friendly manual.”
Complimentary design and project development assistance will be provided from Daicel Arbor’s team of expert scientists, as well as probe design for any custom DNA-Seq and RNA-Seq application. Contact our scientists today to get started on your next NGS project. Learn more by visiting https://arborbiosci.com/genomics/targeted-sequencing/mybaits/.
About Daicel Arbor Biosciences
Daicel Arbor Biosciences, a subsidiary of Chiral Technologies, Inc. (part of Daicel Corporation), is a development and manufacturing company founded by scientists to serve our peers in molecular biology applications. We are a passionate organization of scientists determined to deliver cost-effective, user-friendly products to researchers of genetics and synthetic biology. The team at Arbor Biosciences prides themselves on providing exceptional customer service and timely technical support to new or advanced users on our array of products. We routinely collaborate with our customers and research partners to develop innovative solutions to address their unique applications.
About Chiral Technologies
Chiral Technologies, Inc., a subsidiary of Daicel Corporation, serves pharmaceutical and other life science industries and offers the largest portfolio of chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into single enantiomers. The company also provides analytical method development and custom separation services. Learn more at www.chiraltech.com.